(TARRYTOWN, N.Y.)Regeneron Pharmaceuticals said Wednesday its drug Arcalyst showed positive results at treating the painful inflammatory disease gout in midstage trials.READ MORE
(TARRYTOWN, N.Y.)Regeneron Pharmaceuticals Inc. and Bayer HealthCare AG said Tuesday their drug candidate VEGF Trap-Eye continued to benefit patients with macular degeneration, which can lead to bl...READ MORE
(NEW YORK)A Lehman Brothers analyst said Regeneron Pharmaceuticals Inc.'s cancer drug aflibercept compares more favorably with Genentech Inc.'s Avastin than investors realize.READ MORE
Among the stock activity stories for Friday, June 6, from AP Financial News: NEW YORK (AP)--Shares of specialty contact lens maker Cooper Cos. fell Friday, despite posting fiscal s...READ MORE
(NEW YORK)The Standard & Poor's SmallCap 600 Index advanced on Thursday, led by Hot Topic Inc. after the teen apparel retailer said its May same-store sales fell less than expected.READ MORE
(NEW YORK)As growth slows in shares of large-cap biotechs and economic woes weigh on the broader markets, investors can find dramatic growth opportunities in many small and midcap biotechs w...READ MORE
(NEW YORK)Shares of biopharmaceutical company Regeneron Pharmaceuticals Inc. fell sharply Wednesday after the company reported that a mid-stage trial of an ovarian cancer drug in development...READ MORE